galactose has been researched along with Agranulocytosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacher, J; Francesconi, A; Francis, P; Hoffman, A; Lee, JW; Peter, J; Pizzo, PA; Shelhamer, J; Walsh, TJ | 1 |
Bakker-Woudenberg, IA; Becker, MJ; de Marie, S; Fens, MH; Hop, WC; Verbrugh, HA | 1 |
Beyreiss, K | 1 |
Braude, AI; Davis, CE; Douglas, H; Sherman, JE; Ziegler, EJ | 1 |
4 other study(ies) available for galactose and Agranulocytosis
Article | Year |
---|---|
Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection.
Topics: Agranulocytosis; Amphotericin B; Animals; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Biomarkers; Bronchoalveolar Lavage Fluid; Ergosterol; Galactose; Kidney Diseases; Life Tables; Liposomes; Lung Diseases; Mannans; Mannitol; Opportunistic Infections; Rabbits; Survival Analysis | 1994 |
Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Biomarkers; Chitin; Drug Therapy, Combination; Female; Galactose; Lung; Mannans; Rats; Survival Analysis; Time Factors | 2002 |
[Exocrine pancreatic insufficiency, neutropenia, metaphyseal dysostosis and growth retardation (Shwachman syndrome) with transient disturbances of carbohydrate metabolism].
Topics: Acidosis; Agranulocytosis; Blood Glucose; Carbohydrate Metabolism; Child, Preschool; Dwarfism; Galactose; Glucose Tolerance Test; Humans; Insulin; Male; Neutropenia; Osteochondrodysplasias; Pancreatic Diseases; Syndrome | 1974 |
Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant.
Topics: Agranulocytosis; Animals; Anti-Bacterial Agents; Carbohydrate Epimerases; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Galactose; Glucose; Immunization, Passive; Klebsiella Infections; Mutation; Rabbits; Sepsis; Uridine Diphosphate Sugars | 1973 |